Cancer Research UK Cambridge Institute

AhCre Mouse

Invented at Cancer Research UK Cambridge Institute

Antigen/Gene or Protein Targets: Cre recombinase under the CYP1A1 promoter.

0 reviews 6 references 0 suppliers

R26(SYNbglA)R Mouse

Invented at Cancer Research UK Cambridge Institute

Antigen/Gene or Protein Targets: SYNbglA/beta-glucosidase

0 reviews 2 references 0 suppliers

HCT 116 BRCA2 -/- [42] Cell Line

Invented at Cancer Research UK Cambridge Institute

Antigen/Gene or Protein Targets: BRCA2

0 reviews 2 references 1 supplier

Anti-TACE, Recombinant [D1 (A12)] (mouse IgG)

Invented by Prof Gillian Murphy at Absolute Antibody Cancer Research UK Cambridge Institute

Fn

Antigen/Gene or Protein Targets: TACE (ADAM17)

0 reviews 2 references 1 supplier

HCT 116 p300 WT Cell Line

Invented at Cancer Research UK Cambridge Institute

Antigen/Gene or Protein Targets: p300

0 reviews 10 references 1 supplier

HCT 116 p300 KO [D10] Cell Line

Invented at Cancer Research UK Cambridge Institute

Antigen/Gene or Protein Targets: p300

0 reviews 10 references 1 supplier

HCT 116 p300 KO [F5] Cell Line

Invented at Cancer Research UK Cambridge Institute

Antigen/Gene or Protein Targets: p300

0 reviews 10 references 1 supplier

HCT 116 p300 KO [F2] Cell Line

Invented at Cancer Research UK Cambridge Institute

Antigen/Gene or Protein Targets: p300

0 reviews 10 references 1 supplier

HCT 116 p300 KO Rescue Cell Line

Invented at Cancer Research UK Cambridge Institute

Antigen/Gene or Protein Targets: p300

0 reviews 10 references 1 supplier

Anti-TACE, Recombinant [D1 (A12)]

Invented by Dr Christopher Tape at Cancer Research UK Cambridge Institute

Fn

Antigen/Gene or Protein Targets: TACE (ADAM17)

0 reviews 8 references 3 suppliers

Cancer Research UK Cambridge Institute is not managing any reagent.

Dr Marta Paez-Ribes

from Cancer Research UK Cambridge Institute

0 reagents 0 reviews

Dr Ilaria Falciatori

from Cancer Research UK Cambridge Institute

0 reagents 0 reviews